Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
PUT
LyondellBasell Industries
LYB
$20.5B
| $40.2M | 0.01% |
695,200
+252,300
| +57% | +$14.7M |
|
1327
PUT
Quest Diagnostics
DGX
$26.9B
| $40.1M | 0.01% |
223,500
+67,800
| +44% | +$11.8M |
|
1328
CALL
Unilever
UL
$140B
| $40.1M | 0.01% |
583,200
+335,911
| +136% | +$23.6M |
|
1329
CALL
The Mosaic Company
MOS
$7.72B
| $40M | 0.01% |
1,095,400
+155,000
| +16% | +$4.97M |
|
1330
Amphenol
APH
$196B
| $39.9M | 0.01% |
404,505
+178,411
| +79% | +$14.6M |
|
1331
CALL
NetApp
NTAP
$36.8B
| $39.9M | 0.01% |
374,300
-20,100
| -5% | -$1.91M |
|
1332
IQVIA
IQV
$42.7B
| $39.9M | 0.01% |
252,978
+235,725
| +1,366% | +$35.5M |
|
|
VRNA
1333
CALL
DELISTED
Verona Pharma
VRNA
| $39.9M | 0.01% |
421,400
-54,800
| -12% | -$4.06M |
|
|
1334
PUT
The Mosaic Company
MOS
$7.72B
| $39.8M | 0.01% |
1,091,900
-143,500
| -12% | -$4.6M |
|
1335
CALL
Carrier Global
CARR
$48.3B
| $39.8M | 0.01% |
543,600
+327,400
| +151% | +$22.2M |
|
1336
CALL
Franco-Nevada
FNV
$52.4B
| $39.8M | 0.01% |
242,700
-89,400
| -27% | -$14.8M |
|
1337
CALL
Ares Management
ARES
$32B
| $39.7M | 0.01% |
229,500
+175,700
| +327% | +$27.8M |
|
1338
CALL
Archer Daniels Midland
ADM
$38.3B
| $39.7M | 0.01% |
752,300
+153,700
| +26% | +$7.48M |
|
1339
Booz Allen Hamilton
BAH
$8.96B
| $39.7M | 0.01% |
381,257
+102,405
| +37% | +$11.5M |
|
1340
PUT
Campbell Soup
CPB
$6.99B
| $39.6M | 0.01% |
1,292,900
+826,300
| +177% | +$29.1M |
|
1341
PUT
Paycom
PAYC
$10.4B
| $39.6M | 0.01% |
171,200
+50,300
| +42% | +$11.9M |
|
1342
Progressive
PGR
$129B
| $39.6M | 0.01% |
148,400
+101,789
| +218% | +$27.9M |
|
1343
CALL
Southern Copper
SCCO
$184B
| $39.6M | 0.01% |
410,682
-114,991
| -22% | -$10M |
|
1344
TJX Companies
TJX
$155B
| $39.5M | 0.01% |
320,261
+217,285
| +211% | +$27.6M |
|
1345
Travelers Companies
TRV
$76.8B
| $39.4M | 0.01% |
147,208
-18,644
| -11% | -$4.92M |
|
1346
CALL
Canadian Natural Resources
CNQ
$103B
| $39.4M | 0.01% |
1,254,100
+66,600
| +6% | +$2.02M |
|
1347
CALL
British American Tobacco
BTI
$121B
| $39.4M | 0.01% |
831,800
+178,100
| +27% | +$7.89M |
|
1348
PUT
Ecolab
ECL
$80.6B
| $39.3M | 0.01% |
146,000
+22,200
| +18% | +$5.64M |
|
1349
RB Global
RBA
$15.8B
| $39.3M | 0.01% |
369,966
-93,597
| -20% | -$9.59M |
|
1350
CALL
CRISPR Therapeutics
CRSP
$5.89B
| $39.3M | 0.01% |
807,100
+463,700
| +135% | +$17.9M |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.